Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure

This study has been completed.
Sponsor:
Information provided by:
Tengion
ClinicalTrials.gov Identifier:
NCT00615043
First received: February 1, 2008
Last updated: December 20, 2010
Last verified: December 2010

February 1, 2008
December 20, 2010
February 2008
September 2008   (final data collection date for primary outcome measure)
Evaluation of bladder tissue from patients undergoing transurethral resection of bladder tumor or other transurethral biopsy procedure [ Time Frame: ongoing throughout study ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00615043 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure
A Multi Center Study to Obtain Bladder Tissue Specimens From Subjects Undergoing Transurethral Resection of Bladder Tumor (TURBT) or Other Transurethral Biopsy Procedures

The objective of the study is to obtain bladder tissue specimens from patients otherwise undergoing cystoscopy for use in research at Tengion, Inc.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

Tissue

Non-Probability Sample

Patients otherwise undergoing TURBT

Bladder Disease
Procedure: Bladder biopsy
provision of bladder tissue via cystoscopic biopsy during planned TURBT
TURBT group
Subjects undergoing transurethral resection of bladder tumor or other transurethral biopsy procedure who agree to provide bladder tissue specimens
Intervention: Procedure: Bladder biopsy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
6
December 2008
September 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects 18-90 years and undergoing TURBT
  • Willing and able to give signed informed consent

Exclusion Criteria:

  • Known active infection
  • Known colonization with MRSA or VRE
  • Receipt of blood or blood products for transfusion during the previous 3 months
Both
18 Years to 90 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00615043
TNG-CL007
No
Sunita Sheth, MD Chief Medical Officer, Tengion, Inc
Tengion
Not Provided
Study Director: Sunita Sheth, MD Tengion, Inc
Tengion
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP